Literature DB >> 25001138

Association of leptin with mortality in patients on maintenance hemodialysis: a prospective study.

Xiaohui Bian, Na Liu, Yu Bai, Liqiang Zheng, Ping He, Xuesong Su, Feng Du, Xu Yang, Detian Li1.   

Abstract

INTRODUCTION: Prior studies evaluating the relationship between leptin and outcomes in chronic kidney disease patients have shown conflicting results. Our aim was to evaluate the association of serum leptin with all-cause and cardiovascular disease (CVD)-related mortality in stable maintenance hemodialysis patients.
MATERIALS AND METHODS: We carried out an observational prospective cohort study of 53 patients on maintenance hemodialysis. The follow-up period was 5 years. Leptin levels were measured at baseline before the start of a hemodialysis session. Proportional hazards models were used to evaluate the relationship between leptin and all-cause and CVD-related mortality.
RESULTS: During the follow-up period, 26 patients (49.1%) died. Fifteen of 26 deaths (57.7%) were attributable to CVD. Cox proportional hazards analysis showed that a leptin level equal to or greate than the median value (3.45 ng/mL) was associated with lower mortality rates (hazard ratio, 0.211; 95% confidence interval, 0.062 to 0.723; P = .01) after multivariable adjustment for potential confounders. However, leptin was not an independent risk factor for CVD-related mortality.
CONCLUSIONS: There was a converse association between the serum leptin concentration and mortality in stable maintenance hemodialysis patients. Low serum leptin concentration is an independent risk factor of all-cause mortality in stable maintenance hemodialysis patients, but may not be linked with CVD-related mortality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25001138

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  5 in total

1.  The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.

Authors:  T Gulin; I Kruljac; L S Kirigin Biloš; M Gulin; M Grgurević; M Borojević
Journal:  Osteoporos Int       Date:  2017-05-13       Impact factor: 4.507

Review 2.  Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

3.  Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease.

Authors:  Patrick J Sweigert; Vinod K Bansal; Debra A Hoppensteadt; Jennifer L Saluk; Daneyal A Syed; Jawed Fareed
Journal:  Int J Angiol       Date:  2016-10-05

4.  Adipokines and coronary artery calcification in incident dialysis participants.

Authors:  Neil Roy; Danny Haddad; Wei Yang; Sylvia E Rosas
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

5.  Association of adipokines with blood pressure, arterial elasticity and cardiac markers in dialysis patients: cross-sectional analysis of baseline data from a cohort study.

Authors:  Wenjin Liu; Lei Jiang; Jianping Chen; Chaoqing Gao; Jianmei Zhou; Jiajun Zhou; Youwei Bai; Hong Chu; Wei Fan; Liang Wang; Zhuxing Sun; Xiurong Li; Junwei Yang
Journal:  Nutr Metab (Lond)       Date:  2017-05-10       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.